A population-based case-control study of CARD15 and other risk factors in Crohn's disease and ulcerative colitis

American Journal of Gastroenterology

Volumn 102, Issue 2, 2007, Pages 313-323

  Brant, Steven R ^a,b   Wang, Ming Hsi ^b   Rawsthorne, Patricia ^c   Sargent, Michael ^c   Datta, Lisa Wu ^a   Nouvet, Franklin ^a   Shugart, Yin Yao ^b   Bernstein, Charles N ^c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15;

ADULT; AGE DISTRIBUTION; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; ETHNICITY; FAMILY HISTORY; FEMALE; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; JEW; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; SMOKING; TOBACCO; ULCERATIVE COLITIS; UNIVARIATE ANALYSIS; WILD TYPE;

ADOLESCENT; ADULT; COLITIS, ULCERATIVE; CROHN DISEASE; DNA; FEMALE; GENOTYPE; HUMANS; JEWS; MALE; MANITOBA; MIDDLE AGED; MUTATION; NOD2 SIGNALING ADAPTOR PROTEIN; POLYMERASE CHAIN REACTION; POPULATION SURVEILLANCE; RETROSPECTIVE STUDIES; RISK FACTORS; SMOKING; URBAN POPULATION;

EID: 33846499006     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2006.00926.x     Document Type: Article

References (60)

1. Orholm M, Munkholm P, Langholz E, et al. Familial occurrence of inflammatory bowel disease. N Engl J Med 1991;324:84-8.
2. Peeters M, Nevens H, Baert F, et al. Familial aggregation in Crohn's disease: Increased age-adjusted risk and concordance in clinical characteristics. Gastroenterology 1996;111:597-603.
3. Yang SK, Loftus EV Jr, and Sandborn WJ. Epidemiology of inflammatory bowel disease in Asia. Inflamm Bowel Dis 2001;7:260-70.
4. Probert CS, Jayanthi V, Hughes AO, et al. Prevalence and family risk of ulcerative colitis and Crohn's disease: An epidemiological study among Europeans and south Asians in Leicestershire. Gut 1993;34:1547-51.
5. Lee YM, Fock K, See SJ, et al. Racial differences in the prevalence of ulcerative colitis and Crohn's disease in Singapore. J Gastroenterol Hepatol 2000;15:622-5.
6. Sandler RS. Epidemiology. In: Targan SR, Shanahan F, eds. Inflammatory bowel disease: From bench to bedside. Baltimore, MD: Williams & Wilkins, 1994:5-30.
7. Brant SR, Shugart YY. Inflammatory bowel disease gene hunting by linkage analysis: Rationale, methodology, and present status of the field. Inflamm Bowel Dis 2004;10:300-11.
8. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001;411:599-603.
9. Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001;411:603-6.
10. Economou M, Trikalinos TA, Loizou KT, et al. Differential effects of NOD2 variants on Crohn's disease risk and phenotype in diverse populations: A metaanalysis. Am J Gastroenterol 2004;99:2393-404.
11. Yamazaki K, Takazoe M, Tanaka T, et al. Absence of mutation in the NOD2/CARD15 gene among 483 Japanese patients with Crohn's disease. J Hum Genet 2002;47:469-72.
12. Inoue N, Tamura K, Kinouchi Y, et al. Lack of common NOD2 variants in Japanese patients with Crohn's disease. Gastroenterology 2002;123:86-91.
13. Leong RW, Armuzzi A, Ahmad T, et al. NOD2/CARD15 gene polymorphisms and Crohn's disease in the Chinese population. Aliment Pharmacol Ther 2003;17:1465-70.
14. Croucher PJ, Mascheretti S, Hampe J, et al. Haplotype structure and association to Crohn's disease of CARD15 mutations in two ethnically divergent populations. Eur J Hum Genet 2003;11:6-16.
15. Stockton JC, Howson JM, Awomoyi AA, et al. Polymorphism in NOD2, Crohn's disease, and susceptibility to pulmonary tuberculosis. FEMS Immunol Med Microbiol 2004;41:157-60.
16. Bonen DK, Nicolae DL, Moran T, et al. Racial differences in NOD2 variation: Characterization of NOD2 in African-Americans with Crohn's disease [abstract]. Gastroenterology 2002;122:A29.
17. Kugathasan S, Loizides A, Babusukumar U, et al. Comparative phenotypic and CARD15 mutational analysis among African American, Hispanic, and White children with Crohn's disease. Inflamm Bowel Dis 2005;11:631-8.
18. Brant SR, Picco MF, Achkar JP, et al. Defining complex contributions of NOD2/CARD15 gene mutations, age at onset, and tobacco use on Crohn's disease phenotypes. Inflamm Bowel Dis 2003;9:281-9.
19. Silverberg MS. The time has come for NOD2/CARD15 testing for families with Crohn's disease: Pro. Inflamm Bowel Dis 2005;11:504-6.
20. Zankel E, Rogler G, Andus T, et al. Crohn's disease patient characteristics in a tertiary referral center: Comparison with patients from a population-based cohort. Eur J Gastroenterol Hepatol 2005;17:395-401.
21. Schlesselman J. Case-control studies. Oxford: Oxford University Press, 1982.
22. Bernstein CN, Wajda A, Svenson LW, et al. The epidemiology of inflammatory bowel disease in Canada: A population-based study. Am J Gastroenterol 2006;101:1559-68.
23. Blanchard JF, Bernstein CN, Wajda A, et al. Small-area variations and sociodemographic correlates for the incidence of Crohn's disease and ulcerative colitis. Am J Epidemiol 2001;154:328-35.
24. Bernstein CN, Blanchard JF, Rawsthorne P, et al. Epidemiology of Crohn's disease and ulcerative colitis in a central Canadian province: A population-based study. Am J Epidemiol 1999;149:916-24.
25. Ilnyckyji A, Blanchard JF, Rawsthorne P, et al. Perianal Crohn's disease and pregnancy: Role of the mode of delivery. Am J Gastroenterol 1999;94:3274-8.
26. Bernstein CN, Blanchard JF, Leslie W, et al. The incidence of fracture among patients with inflammatory bowel disease. A population-based cohort study. Ann Intern Med 2000;133:795-9.
27. Bernstein CN, Blanchard JF, Houston DS, et al. The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: A population-based cohort study. Thromb Haemost 2001;85:430-4.
28. Bernstein CN, Wajda A, Blanchard JF. The clustering of other chronic inflammatory diseases in inflammatory bowel disease: A population-based study. Gastroenterology 2005;129:827-36.
29. Bernstein CN, Blanchard JF, Rawsthorne P, et al. Population-based case control study of seroprevalence of Mycobacterium paratuberculosis in patients with Crohn's disease and ulcerative colitis. J Clin Microbiol 2004;42:1129-35.
30. Gasche C, Scholmerich J, Brynskov J, et al. A simple classification of Crohn's disease: Report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis 2000;6:8-15.
31. Sachar DB, Bodian CA, Goldstein ES, et al. Is perianal Crohn's disease associated with intestinal fistulization? Am J Gastroenterol 2005;100:1547-9.
32. Tang LY, Rawsthorne P, Bernstein CN. In Crohn's Disease is there an association between perineal fistulizing disease and luminal fistulizing disease? A population-based study [abstract]. Gastoenterology 2005;128:A113.
33. Hampe J, Cuthbert A, Croucher PJ, et al. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet 2001;357:1925-8.
34. Cosnes J. Tobacco and IBD: Relevance in the understanding of disease mechanisms and clinical practice. Best Pract Res Clin Gastroenterol 2004;18:481-96.
35. Kyle J. Crohn's disease in the northeastern and northern Isles of Scotland: An epidemiological review. Gastroenterology 1992;103:392-9.
36. Arnott ID, Nimmo ER, Drummond HE, et al. NOD2/CARD15, TLR4 and CD14 mutations in Scottish and Irish Crohn's disease patients: Evidence for genetic heterogeneity within Europe? Genes Immun 2004;5:417-25.
37. Giallourakis C, Stoll M, Miller K, et al. IBD5 is a general risk factor for inflammatory bowel disease: Replication of association with Crohn's disease and identification of a novel association with ulcerative colitis. Am J Hum Genet 2003;73:205-11.
38. McGovern DP, Van Heel DA, Negoro K, et al. Further evidence of IBD5/CARD15 (NOD2) epistasis in the susceptibility to ulcerative colitis. Am J Hum Genet 2003;73:1465.
39. Andruilli A, Annese V, Latiano A, et al. The frame-shift mutation of the NOD2/CARD15 gene is significantly increased in ulcerative colitis: An *IG-IBD study. Gastroenterology 2004;126:625-7.
40. Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005;19(suppl A):5-36.
41. Newman B, Silverberg MS, Gu X, et al. CARD15 and HLA DRB1 alleles influence susceptibility and disease localization in Crohn's disease. Am J Gastroenterol 2004;99:306-15.
42. Helio T, Halme L, Lappalainen M, et al. CARD15/NOD2 gene variants are associated with familially occurring and complicated forms of Crohn's disease. Gut 2003;52:558-62.
43. Hampe J, Grebe J, Nikolaus S, et al. Association of NOD2 (CARD 15) genotype with clinical course of Crohn's disease: A cohort study. Lancet 2002;359:1661-5.
44. Vermeire S, Louis E, Rutgeerts P, et al. NOD2/CARD 15 does not influence response to infliximab in Crohn's disease. Gastroenterology 2002;123:106-111.
45. Cuthbert AP, Fisher SA, Mirza MM, et al. The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology 2002;122:867-74.
46. Lesage S, Zouali H, Cezard JP, et al. CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet 2002;70:845-57.
47. Buning C, Genschel J, Buhner S, et al. Mutations in the NOD2/CARD15 gene in Crohn's disease are associated with ileocecal resection and are a risk factor for reoperation. Aliment Pharmacol Ther 2004;19:1073-8.
48. Ahmad T, Armuzzi A, Bunce M, et al. The molecular classification of the clinical manifestations of Crohn's disease. Gastroenterology 2002;122:854-66.
49. Heresbach D, Gicquel-Douabin V, Birebent B, et al. NOD2/CARD15 gene polymorphisms in Crohn's disease: A genotype- phenotype analysis. Eur J Gastroenterol Hepatol 2004;16:55-62.
50. Annese V, Palmieri O, Latiano A, et al. Frequency of NOD2/CARD15 variants in both sporadic and familial cases of Crohn's disease across Italy. An Italian Group for Inflammatory Bowel Disease Study. Dig Liver Dis 2004;36:121-4.
51. Mendoza JL, Murillo LS, Fernandez L, et al. Prevalence of mutations of the NOD2/CARD15 gene and relation to phenotype in Spanish patients with Crohn's disease. Scand J Gastroenterol 2003;38:1235-40.
52. Nunez C, Barreiro M, Dominguez-Munoz JE, et al. CARD15 mutations in patients with Crohn's disease in a homogeneous Spanish population. Am J Gastroenterol 2004;99:450-6.
53. Giachino D, Van Duist MM, Regazzoni S, et al. Analysis of the CARD15 variants R702W, G908R and L1007fs in Italian IBD patients. Eur J Hum Genet 2004;12:206-12.
54. Cavanaugh JA, Adams KE, Quak EJ, et al. CARD15/NOD2 risk alleles in the development of Crohn's disease in the Australian population. Ann Hum Genet 2003;67:35-41.
55. Vermeire S, Wild G, Kocher K, et al. CARD15 genetic variation in a Quebec population: Prevalence, genotype-phenotype relationship, and haplotype structure. Am J Hum Genet 2002;71:74-83.
56. Sugimura K, Taylor KD, Lin YC, et al. A novel NOD2/CARD15 haplotype conferring risk for Crohn's disease in Ashkenazi Jews. Am J Hum Genet 2003;72:509-18.
57. Bonen DK, Ogura Y, Nicolae DL, et al. Crohn's disease-associated NOD2 variants share a signaling defect in response to lipopolysaccharide and peptidoglycan. Gastroenterology 2003;124:140-6.
58. Tukel T, Shalata A, Present D, et al. Crohn's disease: Frequency and nature of CARD15 mutations in Ashkenazi and Sephardi/Oriental Jewish families. Am J Hum Genet 2004;74:623-36.
59. Newman B, Gu X, Wintle R, et al. A risk haplotype in the Solute Carrier Family 22A4/22A5 gene cluster influences phenotypic expression of Crohn's disease. Gastroenterology 2005;128:260-9.
60. Zhou Z, Lin XY, Akolkar PN, et al. Variation at NOD2/CARD15 in familial and sporadic cases of Crohn's disease in the Ashkenazi Jewish population. Am J Gastroenterol 2002;97:3095-101.